Готові списки джерел за темами / Diabetic Chronic Kidney Disease

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій
  6. Звіти організацій

Добірка наукової літератури з теми "Diabetic Chronic Kidney Disease"

Автор: Grafiati
Опубліковано: 3 червня 2025
Оновлено: 31 липня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Diabetic Chronic Kidney Disease".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Diabetic Chronic Kidney Disease"

1

Yee, J. "Diabetic Kidney Disease: Chronic Kidney Disease and Diabetes." Diabetes Spectrum 21, no. 1 (2008): 8–10. http://dx.doi.org/10.2337/diaspect.21.1.8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Shafi, Salman Tahir, Mohammad Saleem, Wajid Abdullah, Roshina Anjum, and Tahir Shafi. "CHRONIC KIDNEY DISEASE." Professional Medical Journal 23, no. 09 (2016): 1104–9. http://dx.doi.org/10.29309/tpmj/2016.23.09.1706.

Повний текст джерела
Анотація:
Diabetes Mellitus and Hypertension are leading causes of chronic kidneydisease (CKD). There is limited data on frequency of retinopathy attributed to diabetes mellitusor hypertension in CKD patients in local population. Objective: to determine the frequency ofdiabetic and hypertensive retinopathy in patients with CKD not on hemodialysis or peritonealdialysis. Study Design: Cross Sectional. Setting: Nephorology ward at Sharif Medical CityHospital. Period: 6 Month. Methods: All patients between ages of 20-80 years with CKD notpreviously on renal replacement therapy (hemodialysis or peritoneal di
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Punit, Kumar1* Vipul Gupta2 Pranav Gupta3 Reena Tiwari4 Timur Beisenov1. "A Concise Review Study on Diabetic Nephropathy: Risk Factors, Pathogenesis, and Treatment." International Journal of Medical Science in Clinical Research and Review 7, no. 06 (2024): 1358–64. https://doi.org/10.5281/zenodo.14211102.

Повний текст джерела
Анотація:
<strong><u>ABSTRACT</u></strong>: Diabetes-related kidney disease is known as diabetic nephropathy (DN). It is also known as renal disease and manifests progressively over many years. It is assumed that DN will require therapy for about one in five diabetics. In developed countries, diabetic kidney disease is assumed as mainly responsible for end-stage kidney disease. It is suggested that about 40% of cases of diabetes are prone to diabetic kidney diseases. Thus, the incidence of increasing cases of this disease is linked to diabetic patients. Proteinuria is also an important indicator of diab
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Williams, Mark E. "Diabetic Chronic Kidney Disease." Medical Clinics of North America 97, no. 1 (2013): xi—xii. http://dx.doi.org/10.1016/j.mcna.2012.11.005.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Rini, Sulistio, Suharyo Hadisaputro, Lestariningsih Lestariningsih, Heri Nugroho, and Selamat Budijitno. "Faktor Risiko Penyakit Ginjal Kronik Diabetes (PGK-DM) pada Diabetes Mellitus Tipe-2 (Studi di RSUD DR Soedarso Kota Pontianak Provinsi Kalimantan Barat)." Jurnal Epidemiologi Kesehatan Komunitas 3, no. 1 (2018): 101. http://dx.doi.org/10.14710/j.e.k.k.v3i1.4028.

Повний текст джерела
Анотація:
Background: Prevalence of type-2 diabetes mellitus have increased significantly. The increasing number of people with diabetes has a major impact on the development of chronic diabetic kidney disease. The research was aimed to clarify several risk factors of chronic diabetic kidney disease on type-2 diabetes mellitus (CDK-DM).Method: The research was based on case control study design. The number of respondents was 140 respondents consisting 70 cases and 70 controls that met the criteria of inclusion and exclusion. The cases were patients with type-2 chronic diabetic kidney disease stadium 2-5.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Rini, Sulistio, Suharyo Hadisaputro, Lestariningsih Lestariningsih, Heri Nugroho, and Selamat Budijitno. "Faktor Risiko Penyakit Ginjal Kronik Diabetes (PGK-DM) pada Diabetes Mellitus Tipe-2 (Studi di RSUD DR Soedarso Kota Pontianak Provinsi Kalimantan Barat)." Jurnal Epidemiologi Kesehatan Komunitas 3, no. 2 (2018): 101. http://dx.doi.org/10.14710/j.e.k.k.v3i2.4029.

Повний текст джерела
Анотація:
Background: Prevalence of type-2 diabetes mellitus have increased significantly. The increasing number of people with diabetes has a major impact on the development of chronic diabetic kidney disease. The research was aimed to clarify several risk factors of chronic diabetic kidney disease on type-2 diabetes mellitus (CDK-DM).Method: The research was based on case control study design. The number of respondents was 140 respondents consisting 70 cases and 70 controls that met the criteria of inclusion and exclusion. The cases were patients with type-2 chronic diabetic kidney disease stadium 2-5.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Rini, Sulistio, Suharyo Hadisaputro, Lestariningsih Lestariningsih, Heri Nugroho, and Selamat Budijitno. "Faktor Risiko Penyakit Ginjal Kronik Diabetes (PGK-DM) pada Diabetes Mellitus Tipe-2 (Studi di RSUD DR Soedarso Kota Pontianak Provinsi Kalimantan Barat)." Jurnal Epidemiologi Kesehatan Komunitas 3, no. 1 (2018): 101. http://dx.doi.org/10.14710/jekk.v3i1.4028.

Повний текст джерела
Анотація:
Background: Prevalence of type-2 diabetes mellitus have increased significantly. The increasing number of people with diabetes has a major impact on the development of chronic diabetic kidney disease. The research was aimed to clarify several risk factors of chronic diabetic kidney disease on type-2 diabetes mellitus (CDK-DM).Method: The research was based on case control study design. The number of respondents was 140 respondents consisting 70 cases and 70 controls that met the criteria of inclusion and exclusion. The cases were patients with type-2 chronic diabetic kidney disease stadium 2-5.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Rini, Sulistio, Suharyo Hadisaputro, Lestariningsih Lestariningsih, Heri Nugroho, and Selamat Budijitno. "Faktor Risiko Penyakit Ginjal Kronik Diabetes (PGK-DM) pada Diabetes Mellitus Tipe-2 (Studi di RSUD DR Soedarso Kota Pontianak Provinsi Kalimantan Barat)." Jurnal Epidemiologi Kesehatan Komunitas 3, no. 2 (2018): 101. http://dx.doi.org/10.14710/jekk.v3i2.4029.

Повний текст джерела
Анотація:
Background: Prevalence of type-2 diabetes mellitus have increased significantly. The increasing number of people with diabetes has a major impact on the development of chronic diabetic kidney disease. The research was aimed to clarify several risk factors of chronic diabetic kidney disease on type-2 diabetes mellitus (CDK-DM).Method: The research was based on case control study design. The number of respondents was 140 respondents consisting 70 cases and 70 controls that met the criteria of inclusion and exclusion. The cases were patients with type-2 chronic diabetic kidney disease stadium 2-5.
Стилі APA, Harvard, Vancouver, ISO та ін.
9

R Shinde, Shruti, Avinash Chaudhari, and Amar Kulkarni. "Study of Thyroid Profile in Diabetic Versus Non - Diabetic Chronic Kidney Disease Patients." International Journal of Science and Research (IJSR) 13, no. 8 (2024): 1517–22. http://dx.doi.org/10.21275/sr24825130803.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Klimontov, V. V., and A. I. Korbut. "Normoalbuminuric chronic kidney disease in diabetes." Terapevticheskii arkhiv 90, no. 10 (2018): 94–98. http://dx.doi.org/10.26442/terarkh201890104-98.

Повний текст джерела
Анотація:
Urinary albumin excretion (UAE) is widely used in clinical practice as indicator of diabetic kidney disease. According to the classical concept of the natural course of diabetic nephropathy, an increase in UAE usually precedes a decline in renal function. Meanwhile, a growing body of evidences indicates a high prevalence of normoalbuminuric chronic kidney disease (NA-CKD) in diabetic subjects, especially among patients with type 2 diabetes. An increase in NA-CKD prevalence can be results of improved glucose, blood pressure, and lipid control, widespread use of renin-angiotensin system blockers
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Diabetic Chronic Kidney Disease"

1

Wong, May Yue Wai. "Novel anti-fibrotic agents in acute and chronic kidney disease." Thesis, The University of Sydney, 2020. https://hdl.handle.net/2123/22015.

Повний текст джерела
Анотація:
The thesis spans the spectrum of causative and therapeutic aspects of chronic kidney disease (CKD), which is a significant and growing health burden. While it is desirable that these findings will translate into effective strategies to prevent CKD, kidney impairment is frequently diagnosed when advanced renal fibrosis has already developed. Thus, the second part of this thesis focuses on therapy and explores whether anti-inflammatory or anti fibrotic agents such as semicarbazide sensitive amine oxidase (SSAO) inhibitor or cationic-independent mannose 6-phosphate receptor (CI-6MPR) inhibitors s
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Palanca, Ana. "Subclinical atherosclerosis in chronic kidney disease and diabetes." Doctoral thesis, Universitat Autònoma de Barcelona, 2020. http://hdl.handle.net/10803/670707.

Повний текст джерела
Анотація:
La malaltia cardiovascular és la primera causa de morbiditat i mortalitat mundial. Els individus amb diabetis i malaltia renal crònica (MRC) presenten un major risc d’esdeveniments cardiovasculars (ECV) respecte a la població general. En la diabetis, l’increment de el risc cardiovascular és heterogeni i s’ha relacionat amb el grau d’afectació renal. D’altra banda, els algoritmes tradicionals per calcular el risc cardiovascular no traslladen amb suficient precisió el risc futur de ECV. L’avaluació de l’aterosclerosi subclínica (AS) mitjançant ecografia multiterritorial representa una eina vàlid
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Shaman, Ahmed M. "Improving outcomes for patients with chronic kidney disease." Thesis, The University of Sydney, 2020. https://hdl.handle.net/2123/22328.

Повний текст джерела
Анотація:
There is clear evidence in the literature that the global burden of chronic kidney disease (CKD) is increasing. CKD patients are at high risk of cardiovascular morbidity and mortality which appeared to proportionally increase as kidney function deteriorates toward end-stage kidney disease (ESKD) requiring dialysis. Given the increasing prevalence, worsened outcomes associated with CKD as well as the financial cost associated with its management, there is a clear need for evidence-based interventions to lower the risk and improve outcomes in this high-risk population. This thesis aimed at
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Sukkar, Louisa. "Improving outcomes in chronic kidney disease and its associated comorbidities." Thesis, The University of Sydney, 2021. https://hdl.handle.net/2123/25667.

Повний текст джерела
Анотація:
Background: Chronic kidney disease (CKD) and its associated comorbidities such as diabetes and cardiovascular disease (CVD) are major drivers of death and disability around the world. Methods: This thesis by publication aims to examine the burden of CKD and diabetes in the community and explores the ways in which this burden can be ameliorated. These aims are achieved by various methodologies. A novel comprehensive population-based data linkage study is used to estimate CKD and diabetes incidence and associations as well as assesses health service delivery of proven cardioprotective treatments
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Walter, Debra L. "Renal Consequences of Coxsackievirus Infection and Type 1 Diabetes in Non-obese Diabetic Mice." Ohio University / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=ohiou1526020616767063.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Herrera-Añazco, Percy, Alvaro Taype-Rondan, María Lazo-Porras, Quintanilla E. Alberto, Victor Manuel Ortiz-Soriano, and Adrian V. Hernandez. "Prevalence of chronic kidney disease in Peruvian primary care setting." BMJ Publishing Group Ltd, 2017. http://hdl.handle.net/10757/622208.

Повний текст джерела
Анотація:
Background: Chronic Kidney Disease (CKD) is a worldwide public health problem. There are few studies in Latin America, especially in primary care settings. Our objective was to determine the prevalence, stages, and associated factors of CKD in primary care setting. Methods: We did a retrospective secondary analysis of a database from the Diabetes and Hypertension Primary Care Center of the Peruvian Social Security System (EsSalud) in Lima, Peru. We defined CKD as the presence of eGFR <60 mL/min and/or albuminuria >30 mg/day in 24 h, according to Kidney Disease: Improving Global Outcomes
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Glastras, Sarah Jean. "Maternal obesity predisposes offspring towards the development of chronic kidney disease." Thesis, The University of Sydney, 2016. http://hdl.handle.net/2123/15709.

Повний текст джерела
Анотація:
Obesity together with insulin resistance promotes multiple metabolic abnormalities and is strongly associated with increased risk of chronic disease including type 2 diabetes (T2D), cardiovascular disease (CVD) and chronic kidney disease (CKD). The incidence of obesity is rising and affects all different stages of the lifespan. Importantly, obesity in women of reproductive has potential ramifications for offspring health. Maternal obesity is known to influence offspring development of obesity, T2D and CVD. In contrast, the relationship between maternal obesity and CKD has been less clearly def
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Mcdonald, H. I. "The epidemiology of infections among older people with diabetes mellitus and chronic kidney disease." Thesis, London School of Hygiene and Tropical Medicine (University of London), 2015. http://researchonline.lshtm.ac.uk/2528130/.

Повний текст джерела
Анотація:
This thesis describes the epidemiology of community-acquired infections among older people with diabetes without a history of renal replacement therapy, according to markers of chronic kidney disease (CKD): proteinuria and reduced estimated glomerular filtration rate (eGFR). The thesis uses linked electronic health records from primary and secondary care, and mortality records. Among a cohort of 219,145 patients with diabetes aged ≥65 years there was a high burden of community-acquired infection: lower respiratory tract infections (LRTIs) having the highest crude rate (152.7/1,000 years) follo
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Vergara, Arana Ander. "Mecanismos de acción del bloqueo SGLT2 en la protección cardiorrenal en la diabetes tipo 2." Doctoral thesis, Universitat Autònoma de Barcelona, 2021. http://hdl.handle.net/10803/674051.

Повний текст джерела
Анотація:
La malaltia renal diabètica (MRD) és la principal causa d’inici de diàlisi en el món i s’acompanya d’una elevada morbimortalitat. Fins al 2016 només dos grups farmacològics que bloquegen el sistema renina-angiotensina (SRA): els inhibidors de l’enzim convertidor d’angiotensina (IECAs) i els antagonistes el receptor d’angiotensina II (ARA2), van demostrar frenar la progressió de la MRD. Recentment, dos grups farmacològics: els inhibidors del cotransportador de sodi-glucosa tipus 2 (iSGLT2) i els antagonistes selectius del receptor d’endotelina (ARE) han demostrat efectes protectors enfront de l
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Pereira, Filipa Alexandra Antunes Vences de Matos. "Patient associations: raising awareness on chronic diseases." Master's thesis, Universidade de Aveiro, 2015. http://hdl.handle.net/10773/16582.

Повний текст джерела
Анотація:
Mestrado em Biomedicina Farmacêutica<br>The patient associations assume a significant role in representing the patients’ rights, sharing information on the diseases, accessing the available resources, maintaining important interactions with other relevant stakeholders and facing challenges. These organizations provide an important support not only to the patients, but also to their families and friends, who are most of the times their direct caregivers. Currently, the patient empowerment has been highly discussed. This project aims to demonstrate in five different clinical disorders what ar
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Diabetic Chronic Kidney Disease"

1

Tong, Bin. Comorbidity of cardiovascular disease, diabetes, and chronic kidney disease in Australia. Australian Institute of Health and Welfare, 2007.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Tong, Bin. Comorbidity of cardiovascular disease, diabetes, and chronic kidney disease in Australia. Australian Institute of Health and Welfare, 2007.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Wada, Takashi, Kengo Furuichi, and Naoki Kashihara, eds. Diabetic Kidney Disease. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-15-9301-7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Yang, Junwei, and Weichun He, eds. Chronic Kidney Disease. Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-32-9131-7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

S, Cappell Mitchell, ed. Chronic kidney disease. Saunders, 2005.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Kumar, Singh Ajay, ed. Chronic kidney disease. Saunders, 2005.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Piracha, Kashif. Chronic Kidney Disease Complications. Springer Nature Switzerland, 2023. http://dx.doi.org/10.1007/978-3-031-49922-7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

McCauley, Jerry, Seyed Mehrdad Hamrahian, and Omar H. Maarouf, eds. Approaches to Chronic Kidney Disease. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-83082-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Haddad, Maha N., Erica Winnicki, and Stephanie Nguyen, eds. Adolescents with Chronic Kidney Disease. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-97220-6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Weir, Matthew R., and Edgar V. Lerma, eds. Chronic Kidney Disease and Hypertension. Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-1982-6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Diabetic Chronic Kidney Disease"

1

Cai, Ting, and Junwei Yang. "Diabetic Kidney Disease." In Chronic Kidney Disease. Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-32-9131-7_3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Maarouf, Omar H. "Diabetic Kidney Disease." In Approaches to Chronic Kidney Disease. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-83082-3_6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

MacIsaac, Richard J., George Jerums, and Gerald F. Watts. "Diabetic Chronic Kidney Disease." In Diabetes. Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781118405550.ch2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Rosas, Sylvia E., and Samer Nasser. "Diabetic Kidney Disease: Increasing Hope with Transformative Therapies." In Management of Chronic Kidney Disease. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-42045-0_4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Chaudhary, Kunal, J. P. Buddineni, Joshua Botdorf, and Adam Whaley-Connell. "Hypertension in Chronic Kidney Disease." In Diabetes and Hypertension. Humana Press, 2012. http://dx.doi.org/10.1007/978-1-60327-357-2_4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Kara, Meryem Tuncel, Moshe Levi, and Devasmita Choudhury. "Diabetes and Chronic Kidney Disease." In Management of Chronic Kidney Disease. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-54637-2_4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Icks, Andrea, and Michael Koch. "Epidemiology of Chronic Kidney Disease in Diabetes." In Diabetes and Kidney Disease. Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781118494073.ch2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Krikorian, Armand, and Joumana T. Chaiban. "Dyslipidemia in Diabetes Mellitus and Chronic Kidney Disease." In Diabetes and Kidney Disease. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0793-9_12.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Taal, Maarten W., and Barry M. Brenner. "How to Achieve Maximal Renoprotection in Non-Diabetic Chronic Renal Disease." In Improving Prognosis for Kidney Disorders. Springer Netherlands, 2002. http://dx.doi.org/10.1007/978-94-017-1848-6_1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Elger, Meaghan, Arti Sharma Parpia, and Dana Whitham. "Diabetes Mellitus and Chronic Kidney Disease (Stages 1–5)." In Nutrition in Kidney Disease. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-44858-5_11.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Diabetic Chronic Kidney Disease"

1

V, Sivakumar, Dharshini S, Dhanush Kumar M, Shanmugaganesh M, and Vijayalakshmi K. "Early Detection of Chronic Kidney Disease in Diabetic Patients using Explainable AI." In 2025 5th International Conference on Pervasive Computing and Social Networking (ICPCSN). IEEE, 2025. https://doi.org/10.1109/icpcsn65854.2025.11035905.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Sridevi, Parama, Padmapriya Velupillai Meikandan, Paramita Basak Upama, et al. "ML-Based Chronic Kidney Disease and Diabetes Prediction with Feature Effect Analysis Using SHAP." In 2024 IEEE 48th Annual Computers, Software, and Applications Conference (COMPSAC). IEEE, 2024. http://dx.doi.org/10.1109/compsac61105.2024.00117.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Guazzo, Alessandro, Enrico Longato, Gian Paolo Fadini, Giovanni Sparacino, Rema Padman, and Barbara Di Camillo. "Characterization of Chronic Kidney Disease Progression in Patients with Diabetes via Group-Based Multi-Trajectory Modeling." In 2024 46th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2024. https://doi.org/10.1109/embc53108.2024.10781792.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Allam, Zyad, Reem Jamal, Fathan Shajrah, and Sawsan Hilal. "Chronic Kidney Disease Detection: A Comparative study." In 2023 4th International Conference on Data Analytics for Business and Industry (ICDABI). IEEE, 2023. http://dx.doi.org/10.1109/icdabi60145.2023.10629400.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Ravi Kumar, R., Srinivas Mudepalli, V. Sujay, Jayapal Lande, and Sallauddin Mohmmad. "An Empirical Method For Chronic Kidney Disease Prediction." In 2024 15th International Conference on Computing Communication and Networking Technologies (ICCCNT). IEEE, 2024. http://dx.doi.org/10.1109/icccnt61001.2024.10724236.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Rani, Ritu, Kanwarpartap Singh Gill, Deepak Upadhyay, and Swati Devliyal. "XGBoost-Driven Insights: Enhancing Chronic Kidney Disease Detection." In 2024 5th International Conference on Smart Electronics and Communication (ICOSEC). IEEE, 2024. http://dx.doi.org/10.1109/icosec61587.2024.10722440.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Kumar, Ashish, Aadrika Singh, Aditya Saxena, Aniket Thakur, and Ayush Kumar Bhartiya. "Enhanced Predictive Modeling for Chronic Kidney Disease Diagnosis." In 2024 1st International Conference on Advanced Computing and Emerging Technologies (ACET). IEEE, 2024. http://dx.doi.org/10.1109/acet61898.2024.10730144.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

P, Patil Dilip, Indranil Jayant Kulkarni, and Rohan S. Phatak. "Cardiac Function Evaluation in Chronic Kidney Disease Patients." In 2024 International Conference on Healthcare Innovations, Software and Engineering Technologies (HISET). IEEE, 2024. http://dx.doi.org/10.1109/hiset61796.2024.00020.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Santhiya, K., D. Murugan, and K. Navaz. "Chronic Kidney Disease Prediction Using Machine Learning Algorithms." In 2024 International Conference on Integration of Emerging Technologies for the Digital World (ICIETDW). IEEE, 2024. https://doi.org/10.1109/icietdw61607.2024.10939413.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Thaney, Rohan, Shivani Shivani, Jothikumar C, and V. Nallarasan. "Chronic Kidney Disease Detection using Deep Learning Models." In 2024 International Conference on Distributed Systems, Computer Networks and Cybersecurity (ICDSCNC). IEEE, 2024. https://doi.org/10.1109/icdscnc62492.2024.10939493.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Diabetic Chronic Kidney Disease"

1

Murphy-Ullrich, Joanne E. The Endoplasmic Reticulum Stress Protein Calreticulin in Diabetic Chronic Kidney Disease. Defense Technical Information Center, 2015. http://dx.doi.org/10.21236/ada624022.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Zhang, Mingzhu, Wujisiguleng Bao, Luying Sun, Zhi Yao, and Xiyao Li. Efficacy and safety of finerenone in chronic kidney disease associated with type 2 diabetes: meta-analysis of randomized clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.3.0020.

Повний текст джерела
Анотація:
Review question / Objective: To assess the beneficial effect and safety of finerenone for patients with chronic kidney disease associated with type 2 diabetes. Condition being studied: Chronic kidney disease (CKD) is a major contributor to morbidity and mortality from non-communicable diseases, affecting almost 700 million people worldwide. Approximately 40% of patients with diabetes have CKD, which exposes them to a 3-fold higher risk of cardiovascular death versus those with T2D alone. Strategies to protect the kidneys of patients with CKD and T2D may reduce their risk of cardiovascular even
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Husidic, Dejvid. The Effect of SGLT-2 Inhibitors in Non-Diabetic Patients with Diseases Such as Congestive Heart Failure and Chronic Kidney Disease. Iowa State University, 2022. http://dx.doi.org/10.31274/cc-20240624-1425.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Yu, Winifred W., Elise Digga, Courtney Luterbach, et al. Linking Dental Services to Treatment Outcomes for Chronic Kidney Disease: A Rapid Response Review. Agency for Healthcare Research and Quality, 2024. https://doi.org/10.23970/ahrqepcrapid_dental_kidney.

Повний текст джерела
Анотація:
Summary: Notwithstanding the gaps noted above or the heterogeneity in the studies, the patient population or periodontitis severity, there is consistent evidence showing a reduction in inflammation post-periodontal treatment in patients with CKD. The evidence for mortality and cardiovascular outcomes also offers evidence (although weak) that these outcomes may be favorable to patients with CKD in the medium term. The Centers for Disease Control recommends oral health maintenance for patients with diabetes. CKD is common in people with type 1 and type 2 diabetes. Approximately 1 in 2 adults wit
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Horvit, Andrew, and Donald Molony. A Systematic Review and Meta-Analysis of Mortality and Kidney Function in Uranium – Exposed Individuals. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.4.0122.

Повний текст джерела
Анотація:
Review question / Objective: 1) In humans, how does environmental and/or occupational exposure to uranium affect the risk of mortality due to primary kidney disease compared to unexposed individuals? (2) In humans, how does environmental and/or occupational exposure to uranium affect the risk of developing kidney failure compared to unexposed individuals? Eligibility criteria: We included cohort studies that evaluate the risk of CKD/ESKD due to uranium exposure. We also included cohort studies that evaluate standardized mortality due to all-cause mortality, kidney cancer, chronic kidney diseas
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Gupta, Shikhar, Mehtab Ahmed, Sayema ., Azam Haseen, and Saif Quaiser. Relevance of Preoperative Vessel Mapping and Early Postoperative Ultrasonography in Predicting AV Fistula Failure in Chronic Kidney Disease Patients. Science Repository, 2024. http://dx.doi.org/10.31487/j.rdi.2023.02.02.

Повний текст джерела
Анотація:
Introduction: The increasing prevalence of chronic kidney disease (CKD), coupled with advancements in the diagnosis and treatment of renal diseases and improvements in life expectancy, has led to a greater number of patients requiring hemodialysis. The preferred method of vascular access for hemodialysis is AV fistula formation; however, it is associated with a high rate of failure. In our prospective study, we focused on 40 CKD patients planned for initiation of maintenance hemodialysis. Methods: We employed preoperative ultrasound mapping to assess cephalic vein diameter, compressibility, an
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Choi, Chiwon, Myeong Gyu Kim, and Jae Hyun Kim. Effect of Xanthine Oxidase Inhibitors on Renal Function in Chronic Kidney Disease Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.5.0024.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Zhu, Huafeng, Haixing Fang, Qunfeng Xia, Jianfeng Cai, and Tianwei Fu. Finerenone reduces risk of cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.3.0052.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Shah, Vallabh, Yiliang Zhu, Jessica Reno, Kevin English, Vernon Pankratz, and Mark Unruh. Effect of COVID-19 Pandemic on Healthcare Access, Anxiety, and Health-Related Behaviors among American Indian People with or at Risk for Diabetes or Chronic Kidney Disease. Patient-Centered Outcomes Research Institute (PCORI), 2024. http://dx.doi.org/10.25302/01.2024.ad.151133553_c19.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Nelson, Julie. Feline chronic kidney disease: Pathophysiology and diagnosis. Iowa State University, 2021. http://dx.doi.org/10.31274/cc-20240624-721.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Diabetic Chronic Kidney Disease" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії